Net Health (US) acquired Tissue Analytics Inc., a wound care technology company based in the United States, to expand its leadership position within the wound care market and accelerate the delivery of next-generation wound care technology solutions, including predictive analytics. The deal closed on May 14, 2020, with no financial terms disclosed.

AcquirerNet Health (US)
TargetTissue Analytics Inc. (US)
Deal ValueUndisclosed
Type of DealAcquisition
Date AnnouncedMay 14, 2020
Date ClosedMay 14, 2020
Buy-side AdvisorsNot Disclosed
Sell-side AdvisorsNot Disclosed
Legal Advisors (Acquirer)Not Disclosed
Legal Advisors (Target)Not Disclosed

Deal Mechanics:

The acquisition of Tissue Analytics Inc. by Net Health closed on May 14, 2020, with no financial terms disclosed.

Strategic Rationale:

Net Health aims to solidify its position in the wound care market through this deal, leveraging Tissue Analytics' expertise and technology to deliver predictive analytics solutions that will enhance the quality of patient care. The acquisition highlights Net Health's commitment to integrating advanced technologies into clinical workflows.

Financial Context:

Given the undisclosed nature of financial terms, specific financial details such as purchase price or earn-out provisions are not available for this deal. However, it is evident that the strategic value of Tissue Analytics' technology and market presence played a significant role in Net Health's decision to acquire the company.

Advisors:

No information on advisors involved was disclosed at the time of the transaction.

Outlook:

The acquisition is expected to enhance Net Health's capabilities and further its strategic goals in delivering innovative wound care solutions. With this move, Net Health seeks to leverage Tissue Analytics' technology platform to drive operational efficiencies and improve patient outcomes.